US Patent Issued to VIRGINIA TECH INTELLECTUAL PROPERTIES on Jan. 27 for "Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies" (Virginia Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,535,481, issued on Jan. 27, was assigned to VIRGINIA TECH INTELLECTUAL PROPERTIES INC. (Blacksburg, Va.).

"Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies" was invented by Brandon L. Jutras (Blacksburg, Va.) and Christine Jacobs-Wagner (Blacksburg, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method of diagnosing Lyme disease in a subject comprising measuring the level of B. burgdorferi peptidoglycan or the level of an antibody that specifically binds to B. burgdorferi peptidoglycan ("anti-peptidoglycan agent"). The present disclosure...